Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3657_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать

Endoleak

BrianC.Gardner andSaherS.Sabri
19

Pathophysiology

Abdominal aortic aneurysm is the abnormal enlargement of the aorta, most often due to weakening of the vessel wall. Pathologically, wall degeneration is a complex combination of inammation, smooth muscle cell death, and extracellu­lar matrix changes. These typically occur in the elderly and more often in males. The leading risk factor for develop­ment is a smoking history [1]. They tend to run in families. Abdominal aortic aneurysms are only detected on physical exam in 30–40% of patients as a pulsatile abdominal mass [1]. Clinically, patients sometimes present with abdominal pain, although they can also be completely asymptomatic. Due to unreliable physical exam ndings, the United States Preventive Task Force recommends screening ultrasound be performed in male smokers age 65–75 [1]. Abdominal aor­tic aneurysms should be treated if equal to or greater than
5.5cm or if the aneurysm has enlarged more than 1cm in a year due to the increased risk of rupture [1]. There is a greater than 50% mortality rate for patients with abdominal aortic aneurysm rupture prior to even presenting to a hospi­tal, and of the patients that do make it to a hospital, there is about a 50% mortality rate during attempted repair [1]. Historically, abdominal aortic aneurysms were repaired by open surgery; however, up to 70% of repairs are now performed using covered stents deployed within the aortic lumen known as endografts [2].
Endografts serve as a conduit within a vessel to exclude a
diseased segment from systemic arterial pressurization. Juan
B. C. Gardner · S. S. Sabri (*) University of Virginia Health System, Department of Radiology and Medical Imaging, Charlottesville, VA, USA e-mail: bg5h@virginia.edu; saher.s.sabri@medstar.net
Key Point
The USPTF recommends screening US in male smokers 65–75years of age to evaluate for AAA.
Parodi developed the rst endograft in 1990 [3]. Endografts can also be used in the setting of arterial dissection to main­tain patency of the vessel true lumen. Endograft placement is much less invasive than the traditional open surgical repair. In the appropriate patient, endografts can be deployed using only percutaneous access with introducer sheaths in the bilateral femoral arteries.
Endoleak is a term used to describe a condition following endovascular repair of the aorta in which blood ow is main­tained outside the lumen of the endograft and within the excluded portion of aneurysm sac [4]. Endoleaks usually need to be treated or at least monitored, because they allow for pressurization of the excluded vessel and, in the setting of aneurysm, can lead to continued aneurysmal expansion and eventually rupture [5]. According to a recent review, endole­aks are detected in about 25% of patients following endovas­cular repair of an aneurysm of the abdominal aorta [6].
Endoleaks are classied based on the mechanism of the leak (Fig. 19.1). Type I endoleaks are dened by leakage around either the proximal (type Ia) or the distal (type Ib) aspect of the endograft. Type II endoleaks occur when the excluded sac is pressurized by afferent and efferent arteries excluded by the graft. Afferent arteries bring blood into the excluded aneurysm sac, and efferent arteries drain blood away from the aneurysm sac. This constant afferent and efferent arterial ow prevents thrombosis of the excluded aneurysm sac. Type III endoleaks involve a defect in the graft, either between components of the endograft or second­ary to a puncture of the graft itself [7]. Type IV endoleaks are
© Springer International Publishing AG, part of Springer Nature 2018 N. A. Keefe et al. (eds.), IR Playbook, https://doi.org/10.1007/978-3-319-71300-7_19
219
220
B. C. Gardner and S. S. Sabri
Fig. 19.1 Types of endoleaks
dened by leakage through the covered endograft material due to porosity, but are uncommon with modern endograft materials [8]. Type V endoleaks are secondary to a phenom­enon known as endotension [9]. The exact mechanism of endotension is somewhat controversial, but when present, there is continued expansion of the excluded aneurysm sac without an identiable source of endoleak on imaging [10]. The most common type of endoleak is type II, making up to around 44% of all endoleaks [7, 11]. Type II endoleaks most commonly involve the lumbar and inferior mesenteric arter­ies [11]. Endoleaks are also characterized according to the timing of onset, with “early” endoleaks occurring within 30 days of endograft placement and “late” endoleaks pre­senting thereafter [11].
Arterial anatomy of the proximal and distal attachment sites or “landing zones” can determine the endograft treatment strategy; some types of landing zones can increase the risk of endoleak occurrence [7]. Abdominal aortic aneurysms can be categorized based on the location of the aneurysm in relation to the renal arteries. Infrarenal abdominal aortic aneurysms are aneurysms located below the level of the renal arteries with a segment of normal aorta between the renal arteries and the aneurysm. This segment is also known as the “neck,” which is used as the proximal attachment site for the endograft [12]. Characteristics of the proximal neck that increase the risk of type Ia endoleak
include a relatively short neck (typically dened as <1cm), an angulated neck (>60 degree angulation), and intraluminal calcication or thrombus [13]. Additional types of abdominal aortic aneurysms include juxtarenal aneurysms which terminate just below the level of the renal arteries, pararenal aneurysms which extend up to and involve the renal arteries, and suprarenal aneurysms which extend above the renal arteries. In some of these cases, special endografts such as fenestrated endografts with suprarenal xators can be used to repair these types of aneurysms, with an uncovered portion of the endograft at the level of the renal arteries to maintain blood ow to the kidneys (refer to Chap. 17 for more infor­mation on aneurysms) [13].
Key Point
Increased risk of type Ia endoleak:
• Short proximal neck
• Angulated proximal neck
• Intraluminal calcication or thrombus of the landing zone
Increased risk of type Ib endoleak:
• Aneurysmal or tortuous iliac arteries
19 Endoleak
221
Consideration must also be made for the distal landing zone. Today’s endografts are bifurcated grafts made up of modular components with two limbs that extend into the common iliac arteries [11]. Deployment of an endograft can be difcult in the setting of aneurysmal or tortuous iliac arter­ies, which make poor landing zones and can lead to a poor seal with the arterial wall [8]. In the setting of a poor distal landing zone, one of the endograft limbs can be extended inferiorly beyond the common iliac artery into the external iliac artery. Prior to endograft deployment into the external iliac artery, the ipsilateral internal iliac artery, also known as the hypogastric artery, should be embolized to prevent a future type II endoleak [1]. Extension of an endograft into the bilateral external iliac arteries is not routinely performed due to concerns for buttock claudication and erectile dysfunction, although this can be performed in some high-risk patients [1].

Clinical Indication

Patients with endoleaks can present with abdominal pain due to an expanding aneurysm, but most endoleaks are asymp­tomatic and identied on routine imaging, either during the placement of the endograft with digital subtraction angiogra­phy (DSA) or on follow-up evaluation using CT, MRI, or ultrasound.
Type I–IV endoleaks can be diagnosed by digital subtrac­tion angiography at the time of endograft deployment. Type V endoleaks, on the other hand, are diagnosed in the setting of a continually expanding aneurysm sac without another endoleak type identied on imaging during follow-up CT angiography, MRI, or ultrasound. In type Ia and Ib endole­aks, contrast will be seen quickly ling either the superior or inferior aspect of the aneurysm sac around the endograft dur­ing the injection of contrast. In type II endoleaks, a vessel excluded by the endograft (usually a lumbar artery or the inferior mesenteric artery) is identied either lling or drain­ing the aneurysm sac. In type III endoleaks, contrast lls the aneurysm sac through a defect in the endograft, either at a junction of the components or at a defect in the graft. Type IV endoleaks could be historically identied on DSA imme­diately post endograft placement, but are uncommon with modern graft materials [8].
Key Point
CTA is the gold standard for evaluation of endoleak.
Following placement of endografts, patients must be fol­lowed with surveillance imaging to detect an endoleak that was not identied during deployment, any further growth of
Table 19.1 Imaging surveillance modalities for endoleaks
Imaging surveillance modalities for endoleaks
Advantages Disadvantages
CTA Gold standard
Rapid examination
MRI No ionization
radiation
Ultrasound No ionization
radiation
Exposure to ionization radiation Use of potentially nephrotoxic IV contrast Susceptible to beam hardening artifact Use of potentially nephrotoxic IV contrast Risk of nephrogenic sclerosing brosis (NSF) Susceptible to artifacts Higher cost and longer exam time Accuracy dependent on skill of technologist Limited in large patients and extensive bowel gas
the aneurysm sac, or evidence of device complication such as graft migration [6]. Surveillance imaging modalities include CTA, MRI, and ultrasound (Table19.1). Currently, CT angiography is the most commonly used imaging modal­ity for follow-up and is considered the gold standard [6, 11]. Multiphase CT angiography examinations are employed with unenhanced, arterial phase, and delayed phase imaging [8]. The recommended follow-up interval using CT angiog­raphy is at 1month, 6months, and 1year following endo­graft deployment, with annual examinations thereafter for lifelong surveillance [8].
The potential adverse effects of CT angiography include exposure to ionizing radiation and the use of intravenous contrast agents that can cause renal damage, particularly in the setting of acute kidney injury or baseline chronic kidney disease [6, 14]. Another issue with CT angiography is the endograft material, and embolization materials can cause beam hardening artifact that can obscure potential sources of endoleak [14]. Ultrasound is another imaging modality that can be used to detect endoleaks with the benet of no ioniz­ing radiation exposure. Duplex ultrasound and contrast­enhanced ultrasound are methods of performing ultrasound evaluation. Duplex ultrasound utilizes the Doppler effect of sound waves to detect ow, such as around the endograft in cases of endoleak. Contrast-enhanced ultrasound uses micro­bubbles that are injected intravenously as a contrast agent to detect ow [6]. MRI is another imaging modality, which unlike CTA does not involve exposure to ionizing radiation. Some studies have shown MRI superiority compared to CT at detecting endoleaks, particularly type II [8, 14]. MRI can be limited by susceptibility artifacts caused by the endograft material that disrupt MRI signal characteristics particularly near the endograft, potentially blocking visualization of an endoleak [15]. Other drawbacks to MRI include the higher cost compared to other modalities and the longer examina­tion times [6, 16].
222
B. C. Gardner and S. S. Sabri

Conventional Therapy

Compared to the traditional repair of abdominal aortic aneu­rysms using open surgery, endografts have superior periop­erative and early morbidity and mortality rates [17, 18, 19]. However, multiple randomized control trials have not shown a signicant difference in overall long-term mortality between endovascular and surgical repairs [20]. Additionally, randomized control trials have shown a signicant increase in secondary interventions following endograft repair when compared to open repair of abdominal aortic aneurysms [21]. The most common complications in endograft repair that necessitate secondary intervention are endoleaks and graft migration [21]. For this reason, endograft patients must be followed with lifelong imaging surveillance [19].
With regard to endoleak treatment following endovascular stent placement, type I and type III endoleaks must be treated immediately as these types of endoleaks are characterized by high pressure within the aneurysm sac. The other types of endoleaks do not necessarily need to be treated immediately and can be followed as long as the aneurysm sac size is stable. In fact, persistent type II endoleaks have not been shown to have an increase in aneurysm-related mortality [22]. Also, stable type II endoleaks demonstrate a comparable rate of rup­ture compared to stable aneurysms without an endoleak [23]. If the decision is made to perform a repair for an endoleak, endovascular techniques are usually attempted rst instead of surgical repair (Table 19.2). Many patients initially selected for endograft placement have signicant comorbidities that make them poor surgical candidates [24]. However, elective open surgical repair of type I or III endoleaks or endograft migration following endograft placement in which further endovascular treatment is not possible has been shown to have
similar mortality rates of about 3% as a primary open repair of abdominal aortic aneurysm [18, 25].

Interventional Therapy

Endovascular treatment of endoleaks depends on the type of endoleak encountered:
Type IEndoleaks
Type I endoleaks are typically high-pressure endoleaks and therefore warrant treatment immediately upon detection (Fig.19.2).
There are a variety of endovascular treatment options for type Ia endoleaks. First, the proximal endograft can be secured to the vessel wall using a relatively noncompliant balloon [1]. A large vessel balloon expandable stent can be used to reinforce the proximal aspect of the endograft. Endovascularly placed staples can also be used to secure the stent to the vessel wall. Additionally, the proximal aspect of the endograft can be extended superiorly with an additional
Table 19.2 Management of type II endoleaks
Decrease in sac size No therapy Increase in sac size Endovascular/surgical treatment Stable sac size Consider treatment in the presence of
predictors of persistent endoleaks:
Numerous collaterals (>3 vessels) Large central nidus (>15 mm) High ows (velocities >100 cm/sec) Chronic anticoagulation
Fig. 19.2 (a) Angiography demonstrates a type Ia endoleak along
the proximal aspect of the endograft below the left renal artery (white arrowheads). (b) Following deployment of a Palmaz balloon
expandable stent within the proximal aspect of the endograft, the endoleak is no longer present
19 Endoleak
cuff if the neck provides enough space for deployment [16, 19]. If the neck is not sufcient, fenestrated extension cuffs or chimney grafts can be placed in order to extend the endograft superior to the renal arteries [2, 19]. Alternatively, embolic agents including coils, Onyx (Medtronic, St. Paul MN), or cyanoacrylate can be placed to ll the space between the endograft and the aortic neck [11, 16]. This space is accessed by catheterization from the aorta or using translumbar aneu­rysm puncture (see below). Of note, coils and embolic agents can create beam hardening artifact on follow-up CT angiog­raphy that can possibly limit future surveillance examina­tions [19].
Type Ib endoleaks can be treated with many of the same techniques as type Ia endoleaks, but are usually treated by extending the distal portion of the affected endograft limb with additional stents [1, 16]. If the additional stents extend over the internal iliac artery, this vessel should be embolized prior to covering to prevent a type II endoleak [16].
Type II Endoleaks
Type II endoleaks are typically low-pressure endoleaks with a lower rate of aneurysm sac expansion and rupture compared to type I and III endoleaks [1]. Some type II endoleaks will resolve without further intervention and therefore do not require immediate treatment [1, 16]. However, treatment is indicated if a type II endoleak results in continued sac expan­sion [1]. In persistent type II endoleaks, there can be more than one inow and outow vessel, making eradication of type II endoleaks difcult [16]. Treatment options include transarterial embolization of the artery supplying the endoleak, translumbar direct percutaneous puncture of the aneurysm sac with embolization, and transcaval puncture of the aneurysm sac with embolization [1]. Choice of technique to use depends on operator preference. Some anatomic factors may favor one technique over others.
The transarterial approach is the most common technique used to treat type II endoleak (Fig.19.3) [26]. In this method, the aneurysm sac and feeding vessel are accessed using endo­vascular technique. For example, through a femoral artery approach, the inferior mesenteric artery can be accessed from the middle colic artery branch of the superior mesenteric artery via the arc of Riolan [16]. The lumbar arteries can be accessed via the internal iliac artery through the iliolumbar arteries [16]. Once the feeding vessel is accessed, it is embo­lized, with additional embolization, when possible, of the aneurysm sac. Embolization materials include coils, cyanoac­rylate, Onyx, and thrombin [19]. Another method of transar­terial approach is accessing the aneurysm sac and feeding vessel from a femoral arterial access by navigating a catheter into the potential space between the distal aspect of the endo­graft and the common iliac artery wall [19].
223
Key Point
Key vascular connections for type II endoleak repair:
SMA ->arc of Riolan ->IMA.
Internal iliac ->iliolumbar arteries ->lumbar arteries.
The How To
Transarterial Embolization of Type II Endoleak
1. Prior to endoleak repair, patients usually undergo cross-sectional imaging, most commonly multi­phase CT angiography to characterize the endoleak and identify a possible endoleak source and poten­tial target for intervention.
2. The patient is placed supine on the angiography table, and the bilateral groins are prepped and draped. A Foley catheter may be placed as proce­dure times can be long.
3. Ultrasound-guided puncture technique is used to access the femoral artery via the Seldinger tech­nique (refer to Chap. 8 for more information).
4. After placement of a sheath and pigtail catheter, an aortogram is performed. Additional selective angiography may be needed to identify the artery supplying the type II leak.
5. The supplying vessel of the endoleak will deter­mine subsequent steps. If the endoleak source is the inferior mesenteric artery, the superior mesen­teric artery will be selected. If the source is a lum­bar artery, the internal iliac artery will be selected (alternatively the aneurysm sac is directly accessed by navigating around one of the distal limbs of the endograft directly into the aneurysm sac).
6. The superior mesenteric artery is selected, and angiography of the SMA is performed.
7. microcatheter and microwire.
8. The inferior mesenteric artery is selected and angiography of the aneurysm sac is performed.
9. At this point, hopefully the afferent and efferent
most commonly a lumbar artery and the inferior mesenteric artery. Results are superior if all can be occluded.
10. The afferent limb, efferent limb, and aneurysm sac are embolized using coils, Onyx, cyanoacrylate, thrombin, or a combination thereof.
11. Follow-up angiography should demonstrate stasis
224
B. C. Gardner and S. S. Sabri
Fig. 19.3 (a) Angiography with a microcatheter advanced into the ilio-
lumbar collaterals using access from the internal iliac artery (black arrowheads) demonstrates a type II endoleak with inow from a lumbar artery (white arrow). (b) Through the microcatheter (black arrow-
heads), embolization is performed with Onyx (black arrow) and place­ment of a coil within the lumbar artery (white arrow). (c) On post-embolization imaging, the Onyx appears as radiopaque material within the aneurysm sac
19 Endoleak
225
The How To
Translumbar Embolization of Type II Endoleak
In the translumbar approach, the aorta is directly punctured with the patient in the prone position using either CT or fluoroscopic guidance (Fig. 19.4) [27]. The approach is usually from the patient’s left side along the lateral aspect of the vertebral bodies to avoid the inferior vena cava, although a right-sided approach is also possible which traverses the IVC en route to the aorta [16, 26]. Once access of the aneurysm sac is established, angiography is performed. Embolization materials include coils, cyanoacrylate, Onyx, and thrombin [16]. One of the risks of this technique is retroperitoneal hemorrhage [16].
1. Prior to endoleak repair, patients usually undergo cross-sectional imaging, most commonly multi­phase CT angiography to characterize the endoleak and identify a possible endoleak source and poten­tial target for intervention.
2. The patient is placed prone on the angiography table. The patient’s back is prepped and draped.
3.
aneurysm sac, usually on the patient’s left side, with the needle running closely alongside the verte-
-
ing that corresponds with the aneurysm sac.
4. Once the aneurysm sac is accessed, successful nee-
blood return. Then the needle is exchanged for a 4 or 5 French catheter.
5. Angiography is performed to identify the afferent and efferent branches.
6. The afferent limb, efferent limb, and aneurysm sac are embolized through a microcatheter as needed using coils, Onyx, cyanoacrylate, thrombin, or a combination thereof.
Type III Endoleaks
Type III endoleaks are diagnosed by injecting the graft to identify contrast quickly exiting the graft into the aneurysm (Fig. 19.5). Type III endoleaks are typically high-pressure endoleaks and therefore are treated immediately upon diagnosis, just like type I endoleaks [30]. Type III endoleaks are usually treated by covering the defect in the graft or the separation of the endograft components with an additional endograft component [1]. Embolization is almost never performed in the setting of type III endoleaks [16].
The How To
Transcaval Embolization of Type II Endoleak
In the transcaval approach, the inferior vena cava is accessed via the femoral vein, and the abdominal aorta aneurysm sac is punctured using a transhepatic portosystemic shunt kit [28]. This method is useful in patients without an identifiable transarterial approach and when the aneurysm sac is located to the right of midline, limiting use of the transarterial or translumbar approaches [28]. These patients require the inferior vena cava to directly oppose the aneurysm sac [28]. Risks of this technique include retroperitoneal hemorrhage and graft puncture with the needle [28].
Another risk is deployment of embolization material such as coils within the IVC, which could potentially migrate to the pulmonary arteries [29].
1. Prior to endoleak repair, patients usually undergo cross-sectional imaging, most commonly multi­phase CT angiography to characterize the endoleak and identify a possible endoleak source and poten­tial target for intervention.
2. The patient is placed supine on the angiography table. The patient’s groins are prepped and draped.
3. The femoral vein is accessed using the Seldinger technique, and a pigtail catheter is advanced into the inferior vena cava. A venogram of the iliac vein and inferior vena cava is performed.
4. Using a transhepatic portosystemic shunt kit, a nee­dle is directed from the inferior vena cava trans­versely into the aneurysm sac at a level in which the inferior vena cava and the abdominal aortic aneu­rysm sac are opposed based on preoperative imaging.
5. The transhepatic portosystemic shunt kit is exchanged for a catheter, and angiography of the aneurysm sac is performed to identify the afferent and efferent branches.
6. The afferent limb, efferent limb, and aneurysm sac are embolized using coils, Onyx, cyanoacry­late, thrombin, or a combination thereof, with care not to deploy embolization material within the inferior vena cava. A successful embolization appears to prevent retroperitoneal hemorrhage in most cases.
Type IV Endoleaks
Type IV endoleaks due to endograft porosity are uncommon with modern endograft materials. When these types of endoleaks were encountered in the past, they typically
226
B. C. Gardner and S. S. Sabri
Fig. 19.4 (a) Preoperative CTA demonstrates a type II endoleak with
contrast enhancement of the aneurysm sac (white arrow). (b) Intraoperative cone beam CT with the patient placed prone demon­strates direct sac puncture using a needle (white arrowhead). (c)
Fig. 19.5 Type III endoleak between the components of the endograft
on angiography, with contrast lling the excluded aneurysm sac (white arrows)
resolved without intervention [1, 16]. Additionally, type IV endoleaks are not associated with increased risk of aneurysm rupture [11].
Type V Endoleaks
Type V endoleaks due to endotension are difcult to treat, as the source of the continued sac expansion is not readily
Angiography through the access needle (black arrow) in a lateral view demonstrates enhancement of the endoleak (black arrowheads) with enhancement of a lumbar artery and the IMA. (d) Embolization mate­rial (Onyx) is seen within the aneurysm sac post-embolization
apparent. These endografts can be treated either by extending the limbs of the endograft or relining the endograft with an additional endograft [1, 11]. If this is not successful, explan­tation of the endograft and open surgical repair may be the only option [1, 16].

References

1. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, Timaran CH, Upchurch GR, Veith FJ.The care of patients with an abdominal aortic aneurysm: the society for vascular surgery practice guidelines. J Vasc Surg. 2009;50(4): S2–49.
2. AbuRahma AF, Hass SM, AbuRahma ZT, Yacoub M, Mousa AY, Abu-Halimah S, Dean LS, Stone PA. Management of immediate post-endovascular aortic aneurysm repair type Ia endoleaks and late outcomes. JAm Coll Surg. 2016;224(4):740–8.
3. Veith FJ, Marin ML, Cynamon J, Schonholz C, Parodi J. 1992: Parodi, Monteore, and the rst abdominal aortic aneurysm stent graft in the United States. Ann Vasc Surg. 2005;19(5):749–51.
4. White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classication, incidence, diagnosis, and management. JEndovasc Ther. 1997;4(2):152–68.
5. Cao P, Verzini F, Parlani G, Romano L, De Rango P, Pagliuca V, Iacono G.Clinical effect of abdominal aortic aneurysm endograft­ing: 7-year concurrent comparison with open repair. JVasc Surg. 2004;40(5):841–8.
6. Guo Q, Zhao J, Huang B, Yuan D, Yang Y, Zeng G, Xiong F, Du X.A systematic review of ultrasound or magnetic resonance imag­ing compared with computed tomography for endoleak detection and aneurysm diameter measurement after endovascular aneurysm repair. JEndovasc Ther. 2016;23(6):936–43.
7. Baum RA, Stavropoulos SW, Fairman RM, Carpenter JP.Endoleaks after endovascular repair of abdominal aortic aneurysms. JVasc Interv Radiol. 2003;14(9):1111–7.
8. Stavropoulos SW, Charagundla SR.Imaging techniques for detec­tion and management of endoleaks after endovascular aortic aneu­rysm repair 1. Radiology. 2007;243(3):641–55.
9. White GH, May J, Petrasek P, Waugh R, Stephen M, Harris J.Endotension: an explanation for continued AAA growth after suc­cessful endoluminal repair. JEndovasc Ther. 1999;6(4):308–15.
10. Veith FJ, Baum RA, Ohki T, Amor M, Adiseshiah M, Blankensteijn JD, Buth J, Chuter TA, Fairman RM, Gilling-Smith G, Harris
19 Endoleak
227
PL. Nature and signicance of endoleaks and endotension: sum­mary of opinions expressed at an international conference. JVasc Surg. 2002;35(5):1029–35.
11. Green N, Sidloff DA, Stather PW, Bown MJ, Sayers RD, Choke E. Endoleak after endovascular aneurysm repair: current status. Rev. Vasc Med. 2014;2(2):43–7.
12. Sternbergh WC, Carter G, York JW, Yoselevitz M, Money SR. Aortic neck angulation predicts adverse outcome with endovas­cular abdominal aortic aneurysm repair. JVasc Surg. 2002;35(3): 482–6.
13. Gallitto E, Gargiulo M, Freyrie A, Massoni CB, Pini R, Mascoli C, et al. Results of standard suprarenal xation endografts for abdominal aortic aneurysms with neck length 10mm in high-risk patients unt for open repair and fenestrated endograft. JVasc Surg. 2016;64(3):563–70.
14. Pitton MB, Schweitzer H, Herber S, Schmiedt W, Neufang A, Kalden P, etal. MRI versus helical CT for endoleak detection after endovascular aneurysm repair. Am J Roentgenol. 2005;185(5): 1275–81.
15. Habets J, Zandvoort HJ, Reitsma JB, Bartels LW, Moll FL, Leiner T, etal. Magnetic resonance imaging is more sensitive than com­puted tomography angiography for the detection of endoleaks after endovascular abdominal aortic aneurysm repair: a systematic review. Eur JVasc Endovasc Surg. 2013;45(4):340–50.
16. Golzarian J, Maes EB, Sun S.Endoleak: treatment options. Tech Vasc Interv Radiol. 2005;8(1):41–9.
17. Greenhalgh RM, The EV.Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised con­trolled trial. Lancet. 2004;364(9437):843–8.
18. Takebayashi S, Hirota J, Mori K, Shuto T, Okamoto K, Sato A, etal. Unique technique for open surgical repair after failed endo­vascular aneurysm repair with proximal anastomoses. Ann Vasc Dis. 2016;9(2):120–4.
19. Barleben A, Inui T, Owens E, Lane JS, Bandyk DF.Intervention after endovascular aneurysm repair: Endosalvage techniques including perigraft arterial sac embolization and endograft relining. Semin Vasc Surg. 2016;29(1):41–9. WB Saunders.
20. United Kingdom EVAR Trial Investigators. Endovascular ver­sus open repair of abdominal aortic aneurysm. N Engl J Med. 2010;2010(362):1863–71.
21. De Bruin JL, Baas AF, Buth J, Prinssen M, Verhoeven EL, Cuypers PW, et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2010;362(20): 1881–9.
22. Jones JE, Atkins MD, Brewster DC, Chung TK, Kwolek CJ, LaMuraglia GM, etal. Persistent type 2 endoleak after endovascu­lar repair of abdominal aortic aneurysm is associated with adverse late outcomes. JVasc Surg. 2007;46(1):1–8.
23. van Marrewijk C, Buth J, Harris PL, Norgren L, Nevelsteen A, Wyatt MG.Signicance of endoleaks after endovascular repair of abdominal aortic aneurysms: the EUROSTAR experience. JVasc Surg. 2002;35(3):461–73.
24. Faries PL, Cadot H, Agarwal G, Kent KC, Hollier LH, Marin ML.Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. JVasc Surg. 2003;37(6):1155–61.
25. Kelso RL, Lyden SP, Butler B, Greenberg RK, Eagleton MJ, Clair DG. Late conversion of aortic stent grafts. J Vasc Surg. 2009;49(3):589–95.
26. Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD. Type II endoleak after endovascular aneurysm repair. Br J Surg. 2013;100(10):1262–70.
27. Binkert CA, Alencar H, Singh J, Baum RA. Translumbar type II endoleak repair using angiographic CT.J Vasc Interv Radiol. 2006;17(8):1349–53.
28. Giles KA, Fillinger MF, De Martino RR, Hoel AW, Powell RJ, Walsh DB. Results of transcaval embolization for sac expansion from type II endoleaks after endovascular aneurysm repair. JVasc Surg. 2015;61(5):1129–36.
29. Stavropoulos SW, Carpenter JP, Fairman RM, Golden MA, Baum RA.Inferior vena cava traversal for translumbar endoleak emboli­zation after endovascular abdominal aortic aneurysm repair. JVasc Interv Radiol. 2003;14(9):1191–4.
30. Bashir MR, Ferral H, Jacobs C, McCarthy W, Goldin M.Endoleaks after endovascular abdominal aortic aneurysm repair: manage­ment strategies according to CT ndings. Am J Roentgenol. 2009;192(4):W178–86.

Traumatic Aortic Injury

MichaelJ.Hagar, AbhijitL.Salaskar, andShawnSarin

Pathophysiology

The rst known description of a traumatic aortic injury was made in 1557 by Vesarius who described a patient that died of aortic rupture after falling from a horse [1]. Traumatic aor­tic injuries can occur from blunt or penetrating trauma. Today, the most common etiology of traumatic aortic injury is blunt trauma. In 274 cases of aortic transections collected from 50 trauma centers over a 2.5-year period, 81% of cases were caused by motor vehicle collisions (MVC). The sever­ity of injury varies with the extent of vessel wall involve­ment, which can range from a small intimal tear with subtle hemorrhage to a complete aortic transection resulting in rapid exsanguination [2].
Aortic transections are extremely rare. On average two to three cases are seen per year in major trauma centers in the United States [3]. However, in a study of 387 blunt trauma deaths, traumatic aortic transections were found to be the second most common cause of death behind head injuries [4]. The risk of death following a traumatic aortic injury is greatest immediately after the accident. It is estimated that only 10–20% of patients with aortic injuries make it to the emergency department alive, and of those, only 60–70% sur­vive [5].
Blunt aortic injuries can result from rapid deceleration injuries such as with a MVC and fall from signicant height
M. J. Hagar George Washington University Hospital, Department of Diagnostic Radiology, Washington, DC, USA
A. L. Salaskar George Washington University Hospital, Department of Interventional Radiology, Washington, DC, USA
S. Sarin ( George Washington University Hospital, Department of Vascular and Interventional Radiology, Washington, DC, USA e-mail: ssarin@gwu.edu
*)
20
or from compression in crushing injuries of the chest [6, 7]. There is no consensus on the exact mechanism of blunt aortic injury; however, there is agreement that the pathophysiology is complex and likely involves a combination of factors including sheer, hydrostatic forces, rapid deceleration, and direct compression [8]. Rapid deceleration results in aortic injury at points of xation, most commonly at the isthmus [9,
10] which is at the junction of the ligamentum arteriosum
and the takeoff of the left subclavian artery. Compression can result in aortic injury when the aorta is pinched between the spine and the sternum, clavicle, or rst rib.
Key Point
Aortic injuries secondary to rapid deceleration most commonly occur at the isthmus.
The common sites of aortic transection according to autopsy studies are reported to be 45–56% at the isthmus, 19–23% ascending aorta, 9–13% descending aorta, 6–8% transverse aortic arch, and 4–5% abdominal aorta [9, 10]. However, these distributions are drastically different when the site of aortic injury is directly observed during surgical repair where 93–97% of aortic injuries were observed at the isthmus [2, 10]. This disparity suggests that patients with aortic transections in sites other than the isthmus rarely sur­vive long enough to reach the hospital [11].
There are various grading systems for traumatic aortic injuries. The most widely accepted grading system proposed by Azizzadeh etal. [12] has been endorsed by the Society for Vascular Surgery. Grading system is as follows (Fig.20.1):
• Grade 1—intimal tear
• Grade 2—intramural hematoma or large intimal ap
• Grade 3—pseudoaneurysm
• Grade 4—free rupture
© Springer International Publishing AG, part of Springer Nature 2018 N. A. Keefe et al. (eds.), IR Playbook, https://doi.org/10.1007/978-3-319-71300-7_20
229